Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4640186
Max Phase: Preclinical
Molecular Formula: C73H93N12O17S+
Molecular Weight: 1442.68
Molecule Type: Unknown
Associated Items:
ID: ALA4640186
Max Phase: Preclinical
Molecular Formula: C73H93N12O17S+
Molecular Weight: 1442.68
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCNC(=S)Nc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)C(N)=O
Standard InChI: InChI=1S/C73H92N12O17S/c1-41(2)34-56(82-65(93)42(3)76-68(96)58(36-45-20-12-9-13-21-45)83-70(98)57(77-43(4)87)35-44-18-10-8-11-19-44)69(97)80-54(23-15-17-33-85(5,6)7)66(94)84-59(40-86)71(99)81-55(30-31-62(90)91)67(95)79-53(64(74)92)22-14-16-32-75-73(103)78-46-24-27-49(52(37-46)72(100)101)63-50-28-25-47(88)38-60(50)102-61-39-48(89)26-29-51(61)63/h8-13,18-21,24-29,37-39,41-42,53-59,86H,14-17,22-23,30-36,40H2,1-7H3,(H14-,74,75,76,77,78,79,80,81,82,83,84,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,103)/p+1/t42-,53-,54-,55-,56-,57-,58-,59-/m0/s1
Standard InChI Key: RCSAYGIFQPCHRP-OVYBDDONSA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1442.68 | Molecular Weight (Monoisotopic): 1441.6497 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):